1
|
Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer.
|
Clin Cancer Res
|
2009
|
3.70
|
2
|
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.
|
Nat Genet
|
2010
|
2.96
|
3
|
Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.
|
Cancer Res
|
2006
|
2.87
|
4
|
Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect.
|
Proteomics
|
2003
|
2.17
|
5
|
DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining.
|
Nucleic Acids Res
|
2004
|
1.67
|
6
|
Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma.
|
Clin Cancer Res
|
2009
|
1.49
|
7
|
MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.
|
Cancer Res
|
2010
|
1.44
|
8
|
Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting.
|
J Pathol
|
2009
|
1.38
|
9
|
A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.
|
Hum Mol Genet
|
2011
|
1.34
|
10
|
Sonic hedgehog regulates prostatic growth and epithelial differentiation.
|
Dev Biol
|
2003
|
1.32
|
11
|
Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
|
Cancer Lett
|
2004
|
1.23
|
12
|
Mining the archival formalin-fixed paraffin-embedded tissue proteome: opportunities and challenges.
|
Mol Biosyst
|
2008
|
1.18
|
13
|
Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.
|
J Pathol
|
2003
|
1.16
|
14
|
Urinary biomarker profiling in transitional cell carcinoma.
|
Int J Cancer
|
2006
|
1.12
|
15
|
Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations.
|
Am J Pathol
|
2002
|
1.10
|
16
|
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma.
|
Proteomics
|
2006
|
1.10
|
17
|
Proteomic analysis of formalin-fixed paraffin-embedded renal tissue samples by label-free MS: assessment of overall technical variability and the impact of block age.
|
Proteomics Clin Appl
|
2013
|
1.08
|
18
|
Initial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigations.
|
J Proteome Res
|
2010
|
1.07
|
19
|
APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer.
|
Clin Cancer Res
|
2005
|
1.03
|
20
|
Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype.
|
Clin Cancer Res
|
2005
|
0.98
|
21
|
Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma.
|
Int J Cancer
|
2005
|
0.96
|
22
|
Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival.
|
Clin Cancer Res
|
2008
|
0.96
|
23
|
Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma.
|
Proteomics
|
2006
|
0.92
|
24
|
Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder.
|
J Pathol
|
2002
|
0.90
|
25
|
Impact of pre-analytical factors on the proteomic analysis of formalin-fixed paraffin-embedded tissue.
|
Proteomics Clin Appl
|
2013
|
0.89
|
26
|
Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line model.
|
Proteomics
|
2009
|
0.89
|
27
|
Metastatic castrate-resistant prostate cancer with a late, complete and durable response to docetaxel chemotherapy: a case report.
|
J Med Case Rep
|
2014
|
0.89
|
28
|
Key clinical issues in renal cancer: a challenge for proteomics.
|
World J Urol
|
2007
|
0.87
|
29
|
Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma.
|
Proteomics
|
2003
|
0.86
|
30
|
Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA-binding activities.
|
Genes Chromosomes Cancer
|
2009
|
0.84
|
31
|
Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapy.
|
Int J Cancer
|
2004
|
0.83
|
32
|
Resistance to the tubulin-binding agents in renal cell carcinoma: no mutations in the class I beta-tubulin gene but changes in tubulin isotype protein expression.
|
Clin Cancer Res
|
2005
|
0.82
|
33
|
Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma.
|
Int J Oncol
|
2012
|
0.81
|
34
|
Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitor.
|
Am J Pathol
|
2003
|
0.78
|
35
|
VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancer.
|
Int J Oncol
|
2013
|
0.76
|
36
|
A practical application of analysing weighted kappa for panels of experts and EQA schemes in pathology.
|
J Clin Pathol
|
2011
|
0.75
|
37
|
Measuring interobserver variation in a pathology EQA scheme using weighted κ for multiple readers.
|
J Clin Pathol
|
2011
|
0.75
|
38
|
The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinoma.
|
BJU Int
|
2008
|
0.75
|